Wearable technology is routinely being batted around these days as the cure-all for everyday health tracking gaps, but Intel’s latest venture is taking that potential to a whole new level. The Michael J. Fox Foundation has tapped the tech giant for a collaboration with the goal of improving the monitoring and treatment of Parkinson’s disease. Announced on Wednesday, the multi-phase research study will launch from a new Intel-built big data analytics platform designed to detect patterns in participant data collected from wearables intended to monitor symptoms. Intel is making good on its major investment in open source software platform Cloudera earlier this year, deploying Cloudera CDH on a cloud infrastructure based on Intel architectures. The chip maker plans to repurpose this platform for other health-related data projects in the future, such as hosting patient, genome and clinical trial data.